In 5–10% of AML cases, inv(16)(p13q22) or t(16;16)(p13;q22) results in the MYH11::CBFB fusion, which is considered a favorable prognostic marker in the disease [27,28]. This evidence concerns the gene CBFB and acute myeloid leukemia.